Insmed | INSM - Market Capitalization

Stock Price
151.65
Daily Change
-5.51 -3.51%
Monthly
-13.44%
Yearly
86.20%
Q1 Forecast
152.04

Insmed reported $23.01B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Cytokinetics USD 6.58B 2.63B Sep/2025
DBV Technologies USD 274M 17M Sep/2025
Dynavax Technologies USD 1.16B 26M Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
Insmed USD 30.44B 11.35B Sep/2025
Novartis USD 303.91B 57.84B Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Ultragenyx Pharmaceutical USD 2.9B 539M Sep/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025